|
|
||||
![]() | ||||
|
|
|
Select from the search options to widen or narrow the search results.
A Breast Cancer Study with Chemotherapy (ECOG 5103)
The purpose of this study is to compare cycles of every 3 week chemotherapy to cycles of every 2 week chemotherapy with or without the research drug bevacizumab To participate in this study you must:
For more information at West Allis please contact, Jill Auer at 414-329-5945 jill.auer@arora.org Principal Investigator, Peter Johnson,MD For more information at Elkorn plsease contact Carol Thomas 262-741-2399 carol.thomas@aurora.org Principle Investigator Rosanna Madamaba M.D. For more information at GreenBay please contact Lori McElrone 920-288-4174 lori.mcelrone@aurora.org Principle Investigator, Dhimant Patel, M.D For more information at Slinger /Milwaukee please contact Pamela Rynes 414-649-6067 pam.rynes@aurora.org Principle Investigator, Jonathan Treisman M.D. For more information at Sheboygan contact Mary Theodoroff 920-457-6800 Ext 2654 mary.theodoroff@aurora.org Principle Investigator, Santhosh Kumar M.D For more information Sinai Milwaukee /VLCC Oshgosh please contact Donna Miller MIlwaukee 414-219-6591 donna.miller@aurora.org or Barbara Esselman Oshgosh 920-456-4880 barbara.esselman@aurora.org Principle Investigator, Magdalena Flejsierowicz M.D.
Clinical trial location(s)AMG - ABMC (incl. VLCC)2845 Greenbrier Road Green Bay, WI 54308-8900 Aurora St. Luke's Medical Center VLCC Sheboygan (AMG) VLCC - Elkhorn VLCC - Sinai VLCC - Slinger VLCC- Oshkosh West Allis Memorial Hospital
[ previous page ]
|
||
|
|
|
|||